Loading...

Tracy Sherertz, MD

TitleAssistant Professor
InstitutionUniversity of California San Francisco
DepartmentRadiation Oncology
Address1600 Divisadero
San Francisco CA 94115
Phone415-353-9634
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Xu MJ, Su D, Deboer R, Garcia M, Tahir P, Anderson W, Kinderman A, Braunstein S, Sherertz T. Palliative Oncologic Care Curricula for Providers in Resource-Limited and Underserved Communities: a Systematic Review. J Cancer Educ. 2017 Dec 20. PMID: 29264703.
      View in: PubMed
    2. Kunos CA, Sherertz T, Mislmani M, Ellis RJ, Lo SS, Waggoner SE, Zanotti KM, Herrmann K, Debernardo RL. Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer. Front Oncol. 2015; 5:126. PMID: 26097831; PMCID: PMC4456851.
    3. Pesec M, Sherertz T. Global health from a cancer care perspective. Future Oncol. 2015; 11(15):2235-45. PMID: 26235185.
      View in: PubMed
    4. Kunos CA, Sherertz T. Long-Term Disease Control with Triapine-Based Radiochemotherapy for Patients with Stage IB2-IIIB Cervical Cancer. Front Oncol. 2014; 4:184. PMID: 25105092; PMCID: PMC4109518.
    5. Kohan AA, Paspulati RM, Sherertz T, Mihaloew H, Herrmann K. Positron emission tomography-magnetic resonance imaging in oncologic diseases of the male and female pelvis. Semin Roentgenol. 2014 Oct; 49(4):334-44. PMID: 25498230.
      View in: PubMed
    6. Sherertz T, Hoggarth M, Luce J, Block AM, Nagda S, Harkenrider MM, Emami B, Roeske JC. Prospective evaluation of dual-energy imaging in patients undergoing image guided radiation therapy for lung cancer: initial clinical results. Int J Radiat Oncol Biol Phys. 2014 Jul 01; 89(3):525-31. PMID: 24751406.
      View in: PubMed
    7. Lyons JA, Sherertz T. Postmastectomy radiation therapy. Curr Oncol Rep. 2014; 16(1):361. PMID: 24318210.
      View in: PubMed
    8. Dall'Era MA, True LD, Siegel AF, Porter MP, Sherertz T, Liu AY. Differential expression of CD10 in prostate cancer and its clinical implication. BMC Urol. 2007 Mar 02; 7:3. PMID: 17335564; PMCID: PMC1829163.
    9. Merrill CE, Sherertz T, Walker WB, Zwiebel LJ. Odorant-specific requirements for arrestin function in Drosophila olfaction. J Neurobiol. 2005 Apr; 63(1):15-28. PMID: 15627264.
      View in: PubMed
    10. Sherertz T, Wallner K, Merrick G, Cavanagh W, Butler W, Reed D, True L. The prognostic significance of Gleason pattern 5 in prostate cancer patients treated with Pd 103 plus beam radiation therapy. Cancer J. 2004 Sep-Oct; 10(5):301-6. PMID: 15530259.
      View in: PubMed
    11. Sherertz T, Wallner K, Merrick G, Ford E, Sutlief S, Cavanagh W, Butler W, True L. Factors predictive of rectal bleeding after 103Pd and supplemental beam radiation for prostate cancer. Brachytherapy. 2004; 3(3):130-5. PMID: 15533804.
      View in: PubMed